Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended		109 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Mar. 31, 2026
Summary of Significant Accounting Policies [Line Items]
Loss recognized from uninsured balances			$ 0
Exercise of Outstanding Stock Options
Summary of Significant Accounting Policies [Line Items]
Antidilutive securities excluded from Computation of diluted net loss per common share	20,859,412	5,445,060